Keywords: naispan, plus, statin, cost-effective, cvd, risk, management

Naispan plus statin cost-effective in CVD risk management

Article | 02 October 2006

Print This

German drugmaker Merck KGaA says that the results of a new study indicate that raising high-density lipoprotein cholesterol levels with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in